What Are the Real Procedural Costs of Bariatric Surgery? A Systematic Literature Review of Published Cost Analyses by Doble, Brett et al.
                          Doble, B., Wordsworth, S., Welbourn, R., Byrne, J., Blazeby, J., Reeves, B.
C., ... Rogers, C. A. (2017). What Are the Real Procedural Costs of Bariatric
Surgery? A Systematic Literature Review of Published Cost Analyses.
Obesity Surgery, 27(8), 2179-2192. https://doi.org/10.1007/s11695-017-
2749-8
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1007/s11695-017-2749-8
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Springer at
https://link.springer.com/article/10.1007%2Fs11695-017-2749-8#copyrightInformation. Please refer to any
applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
REVIEWARTICLE
What Are the Real Procedural Costs of Bariatric Surgery?
A Systematic Literature Review of Published Cost Analyses
Brett Doble1 & Sarah Wordsworth1 & Chris A. Rogers2 & Richard Welbourn3 &
James Byrne4 & Jane M. Blazeby5 & By-Band-Sleeve Trial Management Group
Published online: 26 May 2017
# The Author(s) 2017. This article is an open access publication
Abstract This review aims to evaluate the current literature
on the procedural costs of bariatric surgery for the treatment of
severe obesity. Using a published framework for the conduct of
micro-costing studies for surgical interventions, existing cost
estimates from the literature are assessed for their accuracy,
reliability and comprehensiveness based on their consideration
of seven ‘important’ cost components. MEDLINE, PubMed,
key journals and reference lists of included studies were
searched up to January 2017. Eligible studies had to report
per-case, total procedural costs for any type of bariatric surgery
broken down into two or more individual cost components. A
total of 998 citations were screened, of which 13 studies were
included for analysis. Included studies were mainly conducted
from a US hospital perspective, assessed either gastric bypass
or adjustable gastric banding procedures and considered a
range of different cost components. The mean total procedural
costs for all included studies was US$14,389 (range, US$7423
to US$33,541). No study considered all of the recommended
‘important’ cost components and estimation methods were
poorly reported. The accuracy, reliability and comprehensive-
ness of the existing cost estimates are, therefore, questionable.
There is a need for a comparative cost analysis of the different
approaches to bariatric surgery, with the most appropriate cost-
ing approach identified to be micro-costing methods. Such an
analysis will not only be useful in estimating the relative cost-
effectiveness of different surgeries but will also ensure appro-
priate reimbursement and budgeting by healthcare payers to
ensure barriers to access this effective treatment by severely
obese patients are minimised.
Keywords Adjustable gastric banding . Costs . Bottom-up
costing . Gastric bypass . Gross costing .Micro-costing .
Obesity . Sleeve gastrectomy . Top-down costing
Introduction
Bariatric surgery is considered the most efficacious treatment
for severe and complex obesity [1] and can be performed
using a number of different surgical techniques. In 2013,
Roux-en-Y gastric bypass (RYGB) was the most common
procedure, followed by sleeve gastrectomy (SG) and adjust-
able gastric banding (AGB), accounting for 45, 37 and 10% of
surgeries performed respectively worldwide [2]. Recently,
however, SG has surpassed RYGB as the most common pro-
cedure in some jurisdictions, with SG accounting for over
50% of bariatric surgeries performed in the USA [3].
Evidence from retrospective studies suggest that RYGB
and SG are likely to result in the greatest amount of
weight loss and improvement of comorbidities, but have
greater risks and less flexibility than AGB, which is asso-
ciated with less reliable long-term weight loss [4].
However, evidence from randomised controlled trials
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comparing the different surgeries is limited [5, 6], as is
information on the relative cost-effectiveness of the three
surgery types [7]. The lack of the latter evidence could be
due partly to a dearth of cost information for the three
procedures. Detailed cost estimates (i.e. expenditures in-
volved in acquiring resources that are necessary for the
delivery of care) are also a requisite for the development
of appropriate reimbursement rates by healthcare payers
[8]. For example, the National Health Service (NHS) in
the UK has two main tariffs used to reimburse physicians/
hospitals for performing bariatric surgery [£4028
(US$5771) for AGB and SG and £4608 (US$6602) for
RYGB] [9]. However, the underlying resources and costs
attributed to these tariffs are unclear, which could lead to
either over- or underpayment of providers of bariatric
surgery.
To fill these evidence gaps, a multi-centre randomised con-
trolled trial, known as the By-Band-Sleeve (BBS) study, is
being conducted comparing both the relative effectiveness
and cost-effectiveness of RYGB, AGB and SG [5, 10]. In
comparison to other bariatric surgery trials, the BBS study will
assess both clinical and economic outcomes for the three most
common approaches to bariatric surgery, in the largest sample
size studied in a comparative trial to date (expected to
randomise 447 patients per group), over a substantial follow-
up period (36 months). However, an important first step in
estimating the economic outcomes in the BBS study will be
to obtain detailed and ‘accurate’ costs of the three types of
bariatric surgery.
The costs associated with bariatric surgery are a function of
the resources consumed and the unit costs associated with
those resources. These parameters can be identified using a
number of different approaches, but can broadly be separated
into methods used to identify cost components (gross costing
or micro-costing) [11] and methods used to value cost com-
ponents (top-down costing and bottom-up costing) (see Box 1
for definitions) [12]. The choice of method is usually depen-
dent on the context, data and funding available to conduct a
costing study, but it is important to note that the application of
different methods may result in variations in the magnitude
and therefore the accuracy and reliability of the estimated
costs [13, 14]. Detailed cost estimates, derived using transpar-
ent methods, are not only important to provide appropriate
reimbursement but also act as accurate inputs in analyses com-
paring the relative cost-effectiveness of the different surgical
approaches and will allow healthcare providers to budget ju-
diciously, potentially minimising barriers to access surgery for
the increasing number of severely obese patients [15].
Therefore, our study aimed to review the literature and iden-
tify robust estimates of the procedural costs of the main types
of bariatric surgery. More specifically, we will summarise the
international literature on procedural bariatric surgery costs
and assess their comprehensiveness, accuracy and reliability.
Methods
Eligibility Criteria
Published costing studies in the English language reporting
detailed, per-case (i.e. per-patient) cost estimates associated
with performing any type of bariatric surgery were considered.
To be included, a cost analysis had to report two or more cost
components related to performing the procedure. For exam-
ple, a study reporting a breakdown of the total cost of surgery
in terms of inpatient stay, personnel and equipment costs
would be included in the review. Studies only reporting the
total cost of surgery with no breakdown into individual cost
components (i.e. an aggregated cost) were excluded because it
is impossible to understand from total costs what underlying
resources were included. Studies only reporting detailed total
costs for a single component (e.g. equipment costs) were also
excluded, even if they broke down the single component into
sub-components (e.g. total equipment costs broken down into
maintenance costs, operating costs and personnel costs for
cleaning). Studies only assessing the cost of healthcare
utilisation either before or after bariatric surgery were also
excluded.
Information Sources, Search and Data Collection
Two databases, Ovid MEDLINE and PubMed, were searched
from inception to January 16, 2017 (Appendix). Search terms
were initially developed for three different categories, costing
terminology, types of bariatric surgery and obesity nomencla-
ture, but subsequently refined to increase the sensitivity of the
searches. No restrictions were initially placed on the language
of the articles to ensure a large number of relevant studies
Box 1 Definitions of methods for identifying and valuing cost
components
Methods for identifying cost components
Gross-costing: Involves identifying cost components at a highly
aggregated level (e.g. costing an intervention based only on the
associated inpatient days) [11].
Micro-costing: A precise method, where an attempt is made to identify
every input consumed in the treatment of a particular patient [11].
Methods for valuing cost components
Top-down costing: An approach where relative value units such as
hospital days or some other metric are used to separate out relevant
costs from comprehensive sources (e.g. the finance department’s
annual accounts) and apportion them to individual services or
procedures [12]. For example, the sum of the annual budget of an
intensive care unit and hospital overhead may be divided by the
number of patient days to estimate an average cost per patient per day
[34].
Bottom-up costing: An approach where cost components are valued by
identifying resource use directly employed for a patient, resulting in
patient-specific unit costs [14].
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were not published in languages other than English, but any
studies not reported in English were excluded from the review
during screening. In addition, a hand search of key journals
and the quoted references from the included articles was con-
ducted to identify any additional studies. One author (B.D.)
screened the titles and abstracts of all the citations identified
from the search strategies, reviewed the full-text articles iden-
tified after screening and extracted the data from all included
studies.
Data Items
Study design and population, types of bariatric surgery
assessed, data collection methods and types of costs (i.e.
cost components) included were extracted. Total costs of
the procedure were extracted as well as the cost values
associated with each individual component. Costs are
reported here in the currency and price year originally
listed in the included study. When the price year was
not reported, it was assumed that the price year would
be 1 year earlier than the year in which the study was
published. To compare the cost of bariatric surgery be-
tween different studies, total procedural costs were also
inflated to a 2016 price year. When prices were reported
over multiple years, the most recent price year was used
to inflate the total cost to make a conservative assump-
tion. In terms of currency conversion for studies con-
ducted in different countries, costs were adjusted for
purchasing power parities (PPPs) (to adjust for price
differences between countries, rather than just exchange
rates, which do not take price differences into account)
and converted to 2016 US dollar PPPs [16]. If total
costs were reported in US dollars, but had been con-
verted from the country’s currency in which the study
was conducted, the total cost estimate was first convert-
ed back to the original currency using the exchange rate
provided in the article before inflating, adjusting and
converting to 2016 US dollars.
Assessment of Accuracy, Reliability
and Comprehensiveness
To provide an indication of the accuracy, reliability and com-
prehensiveness of the reported cost estimates, the inclusion of
‘important’ cost components based on criteria outlined by
Ismail et al. [17] for conducting costing analyses of surgical
interventions was assessed. Ismail et al. reviewed costing ap-
proaches for robotic surgeries, in general, and assessed 19
studies, three of which related to bariatric surgery [18–20],
for their consideration of six criteria with the objective to
create and validate a micro-costing methodology that could
be used by surgeons and hospital administrators to evaluate
the cost of implementing new surgical approaches. As
standardised guidance regarding how to conduct a micro-
costing is limited [21, 22], the methodology presented by
Ismail et al. provides one of the only frameworks for the con-
duct of micro-costing studies and has specifically been de-
signed for the evaluation of surgical interventions. The con-
sideration of the six criteria presented by Ismail et al. was
therefore thought to form a standard by which existing cost
analyses could be measured. We have, however, also added an
additional criterion (inclusion of overhead costs) to the six
originally presented by Ismail et al. [17] as exclusion of such
overheads could also affect the accuracy, reliability and com-
prehensiveness of cost estimates reported in the literature. A
study was considered to include one of the ‘important’ cost
components when a separate cost value could be identified for
that individual component. The seven ‘important’ cost com-
ponents included:
1. Cost, not charge data used in the analysis;
2. Operating room costs reported separate from hospital ad-
mission costs;
3. Medical device costs reported (e.g. endoscopy column,
laparoscopic tower);
4. Personnel costs reported (e.g. surgeon, nurse, anaesthesi-
ologist time);
5. Re-usable instrument costs reported (e.g. bowel graspers,
surgical scissors);
6. Disposable instrument/consumables costs reported (e.g.
needles, disposable staplers); and
7. Overhead costs reported.
Reporting of the methods used to identify cost compo-
nents (gross and/or micro-costing) and value cost compo-
nents (top-down and/or bottom-up costing) was appraised.
When methods were not specifically reported, we
assigned the relevant method based on the reported data
collection description for resource items and costs. The
inclusion of specific parameters based on standardised
formulas [17] in the calculation of ‘important’ cost com-
ponents (e.g. medical devices, personnel, re-usable and
disposable instruments) was also evaluated. The parame-
ters of interest included:
1. Capacity adjustment of personnel costs (e.g. adjusting
salary for working days minus paid leave when determin-
ing a per-minute personnel cost);
2. Amortisation or depreciation of medical devices (e.g. al-
locating the acquisition cost of a device over its useful
lifespan);
3. Maintenance fees for medical devices (in addition to the
amortised acquisition cost);
4. Adjustments for medical devices shared across different
procedures (i.e. laparoscopic tower may only be used 50%
of the time for bariatric surgery);
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5. Sterilisation costs of reusable instruments (e.g. personnel
time disinfecting and repackaging reusable instruments);
and
6. Disposal costs of consumables (e.g. the waste manage-
ment costs associated with consumables).
Synthesis of Results
Syntheses of the extracted data were performed to com-
pare study characteristics and cost estimates across studies
as well as combine individual study cost estimates into
summary measures of total procedural costs. Important
study characteristics and detailed cost estimates from the
included studies were summarised in tabular format and
used to evaluate the availability of cost estimates for dif-
ferent types of bariatric surgery, the methods used to col-
lect the cost data and the specific cost components includ-
ed in the analyses. Mean costs and standard deviations
(SD) were calculated for all reported cost estimates to-
gether, estimates derived only from cost data (as charges
do not necessarily reflect the actual cost of the resources
consumed to deliver the surgery) and for different types of
bariatric surgery. The inclusion of ‘important’ cost com-
ponents was also synthesised in tabular format.
Results
Study Selection
The search strategy identified a total of 998 citations. After
removing duplicates (n = 499), 499 unique citations remained
for title and abstract screening, which left 73 unique citations
of interest for full-text review. After full-text review, 13 stud-
ies were selected for detailed review (Fig. 1).
Study Characteristics
Thirteen studies (Table 1) reported detailed procedural
costs [17, 18, 23–33]. The majority of the studies were
conducted from a US hospital perspective [23, 26–30, 32,
33], with the remaining studies taking a European [17, 18,
31], Australian [25] and Brazilian [24] hospital perspec-
tive. Limited details concerning the sources of data were
provided in all the studies. Most commonly, data sources
were simply stated as specific hospital departments or
general hospital databases [17, 24, 28–30]. Other sources
of data included hospital charges or claims data [23, 27,
32, 33], purchase prices [31], a dedicated bariatric surgery
database [26], patient case record forms [25] and a mix of
prospective, retrospective, documentation and finance de-
partment data [18].
A number of different types of bariatric surgery were
costed, but no study assessed the cost of the SG proce-
dure, perhaps as this is a relatively new procedure. One
study reported costs for bariatric surgery, in general [32],
two studies reported costs for different gastric banding
procedures [25, 31] and two studies reported costs for
gastric bypass procedures [17, 24]. The remaining studies
compared the costs of two or more different procedures
[18, 23, 26–30, 33].
Most studies included hospitalisation costs [18, 23, 24,
30–33] and/or the costs of consumables/materials/supplies
[17, 18, 24–27, 30, 33]. Five studies reported costs asso-
ciated with operating room time [18, 24, 26, 27, 30],
personnel/staff costs [17, 23, 25, 29, 32] (note that only
three of these studies [23, 25, 32] explicitly stated that
surgeon/physician fees were included in personnel/staff
costs) and/or the costs of additional procedures [23, 24,
29–31]. Four studies reported costs associated with a spe-
cial instrument or technology [17, 18, 26, 27]. Three stud-
ies reported the cost of medications [23, 24, 29] and/or a
combined cost associated with the operating room, includ-
ing operating room time, supplies, personnel, equipment,
medications and examinations [28, 29, 31]. A few studies
also reported intensive care unit/post-anaesthesia costs
[18, 29], indirect costs (e.g. overhead, housekeeping, ad-
ministrative costs, etc.) [28, 29], anaesthesiology costs
[33] and other miscellaneous costs [30].
Twenty-three total procedural cost estimates were reported
in the 13 included studies, with a mean of $14,389 SD $6110
(range, $7423 to $33,541) (Table 2). Excluding the five stud-
ies that used charge data to estimate total procedural costs left
14 estimates with a mean of $13,993 SD $5441. Five studies
reported ten estimates of total procedural costs for different
types of gastric bypass procedures with a mean of $13,496 SD
$4171. Three studies reported four estimates of total proce-
dural costs for different types of gastric banding procedures,
with a mean of $15,237 SD $8556.
Inclusion of ‘Important’ Cost Components
The majority of studies used cost [17, 18, 24–26, 28, 29, 31]
rather than charge data [23, 27, 32] in their analyses, with two
studies [30, 33] using both (Table 3). All the studies using cost
data reported operating room costs separate from hospital ad-
mission costs, while only two [27, 30] of the four studies using
charge data reported these two costs separately. The remaining
five ‘important’ cost components (medical device, personnel,
re-usable instruments, disposable instruments and overhead
costs) varied in their reporting. Nine studies reported costs
for instruments [17, 18, 24–27, 29, 30, 33], but usually did
not differentiate between re-usable and disposable [18, 24, 25,
29, 30]. Only four studies [17, 18, 25, 29] included five or
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more of the seven important cost components in their
analyses.
Methods and Parameters Used for Calculating
‘Important’ Cost Components
Only one study made specific reference to a method for iden-
tifying cost components [17]. Micro-costing methods were
assumed to be most commonly employed to identify cost
components, but methods of valuing components were not
discernible in the majority of the studies. The inclusion of
specific parameters in the calculation of ‘important’ cost com-
ponents was also poorly reported. Only three studies
amortised the cost [17, 18] or accounted for depreciation
[26] of medical devices over their life span and only two
studies accounted for the cost of maintenance fees [17, 18].
One of the studies reporting a combined operating room cost
also noted that the laparoscopic equipment costs were
amortised [29]. Only one study reported capacity adjusted
personnel costs and accounted for sterilisation costs of reus-
able instruments [17]. No studies made adjustments for med-
ical devices shared across different procedures or included the
disposal costs associated with consumables.
Discussion
This paper presented a systematic review of cost analyses of a
number of different approaches to bariatric surgery for the treat-
ment of severe obesity. From the 13 studies included in the
review, sources and methods of data collection were minimally
reported, making it difficult to ascertain what methods were
used to identify and value cost components. A number of dif-
ferent types of bariatric surgery were costed mainly from a US
hospital perspective, including laparoscopic gastric bypass and
gastric banding procedures, but no study reported a cost for the
Database Search and Hand Search 
Results to January 16, 2017 (n=998) 
Ovid MEDLINE (n=529) 
PubMed (n=465) 
Hand Searching (n=4) 
Records excluded  
(n=426) 
Full-text studies  
assessed for eligibility 
(n=73) 
Studies included (n=13) 
Studies excluded (n=58) 
Not in English (n=1) 
Only budget impact reported 
(n=1) 
Only aggregate labour costs 
reported (n=1) 
Cost analysis of hypothetical 
practice (n=1) 
No costs reported (n=2) 
Only detailed material costs (n=2) 
Commentary/Review (n=5) 
No surgical costs reported (n=7) 
Only aggregate material cost 
reported (n=8) 
Not available (n=4) 
Only aggregate surgical cost 
reported (n=28)
Duplicates removed (n=499) 
Records screened (n=499) 
Id
en
tif
ic
at
io
n 
Sc
re
en
in
g 
El
ig
ib
ili
ty
 
In
cl
ud
e
Fig. 1 Flow diagram for
selection of studies
OBES SURG (2017) 27:2179–2192 2183
T
ab
le
1
Su
m
m
ar
y
of
st
ud
ie
s
re
po
rt
in
g
de
ta
ile
d
pr
oc
ed
ur
al
co
st
s
fo
r
ba
ri
at
ri
c
su
rg
er
y
A
ut
ho
r
[r
ef
]
cu
rr
en
cy
ye
ar
a
St
ud
y
de
si
gn
an
d
po
pu
la
tio
n
Ty
pe
(s
)
of
ba
ri
at
ri
c
su
rg
er
y
D
at
a
co
lle
ct
io
n
m
et
ho
ds
C
os
tc
om
po
ne
nt
s
in
cl
ud
ed
To
ta
l
pr
oc
ed
ur
al
co
st
C
os
tc
om
po
ne
nt
on
e
C
os
tc
om
po
ne
nt
tw
o
C
os
t
co
m
po
ne
nt
th
re
e
C
os
t
co
m
po
ne
nt
fo
ur
C
os
t
co
m
po
ne
nt
fi
ve
St
ud
ie
s
us
in
g
ch
ar
ge
(n
ot
co
st
da
ta
)
C
oo
ne
y
[3
0]
U
SD
20
00
Ju
ne
19
98
to
M
ar
ch
19
99
16
G
B
pr
oc
ed
ur
es
pe
rf
or
m
ed
by
si
ng
le
su
rg
eo
n
at
Pe
nn
St
at
e
H
er
sh
ey
M
ed
ic
al
C
en
te
r
(P
re
gr
ou
p)
co
m
pa
re
d
to
12
G
B
pr
oc
ed
ur
es
pe
rf
or
m
ed
by
sa
m
e
su
rg
eo
n
A
pr
il
to
D
ec
em
be
r
19
99
(P
os
t
gr
ou
p)
Pr
e-
pa
th
w
ay
G
B
(n
=
16
)
an
d
po
st
--
pa
th
w
ay
G
B
(n
=
12
)
C
os
ts
of
ca
re
ob
ta
in
ed
fr
om
ho
sp
ita
lf
in
an
ci
al
in
fo
rm
at
io
n
sy
st
em
us
in
g
co
st
/c
ha
rg
e
ra
tio
s;
O
R
co
st
s
ob
ta
in
ed
fr
om
O
R
in
fo
rm
at
io
n
sy
st
em
R
oo
m
an
d
bo
ar
d,
O
R
,
su
pp
lie
s,
la
bo
ra
to
ry
an
d
ra
di
ol
og
y
an
d
m
is
ce
lla
ne
ou
s
co
st
s;
O
R
tim
e
di
vi
de
d
in
to
an
ae
st
he
si
a
tim
e,
pa
tie
nt
pr
ep
ar
at
io
n
tim
e,
su
rg
ic
al
tim
e
an
d
‘w
ak
e
up
’
tim
e
Pr
e:
$1
0,
17
6
SD
$7
89
Po
st
:
$8
51
1
SD
$7
63
H
os
pi
ta
lr
oo
m
ch
ar
ge
fo
r
L
O
S
Pr
e:
$3
64
1
SD
$3
98
Po
st
:
$2
38
9
SD
$3
47
O
pe
ra
tin
g
ro
om
co
st
s
Pr
e:
$3
46
7
SD
$2
53
Po
st
:
$4
25
1
SD
$1
52
Su
pp
ly
co
st
s
du
ri
ng
in
ho
sp
ita
ls
ta
y
Pr
e:
$1
15
2
SD
$1
94
Po
st
:
$6
79
SD
$1
07
In
-h
ou
se
la
bo
ra
to
ry
st
ud
ie
s
an
d
ra
di
ol
og
y
ex
am
in
a-
tio
ns
Pr
e:
$6
29
SD
$8
4
Po
st
:
$3
12
SD
$1
12
O
th
er m
is
ce
lla
-
ne
ou
s
co
st
s
Pr
e:
$1
09
8
SD
$1
22
Po
st
:
$8
78
SD
$1
79
M
uh
lm
an
n
[2
7]
U
SD
20
02
C
as
e
se
ri
es
of
10
ro
bo
tic
-a
ss
is
te
d
la
pa
ro
sc
op
ic
pr
oc
ed
ur
es
co
m
pa
re
d
to
10
C
L
P
du
ri
ng
th
e
le
ar
ni
ng
cu
rv
e
R
ob
ot
ic
an
d
C
L
P
ea
ch
ha
d:
SA
G
B
(n
=
4)
,
IG
S
(n
=
4)
,
re
vi
si
on
al
ba
ri
at
ri
c
su
rg
er
y
(n
=
2)
It
em
is
ed
ch
ar
ge
s
ca
lc
ul
at
ed
by
th
e
in
st
itu
tio
na
lb
ill
in
g
de
pa
rt
m
en
t;
pe
rs
on
ne
l
ch
ar
ge
s,
O
R
tim
e
an
d
st
af
f
es
tim
at
ed
us
in
g
ch
ar
ge
ra
te
pe
r
m
in
ut
e
ba
se
d
on
m
ed
ia
n
tim
e
fo
r
pr
oc
ed
ur
es
ro
ut
in
el
y
do
cu
m
en
te
d
in
th
e
O
R
da
ta
ba
se
P
ro
ce
du
ra
lc
os
ts
in
cl
ud
ed
op
er
at
io
n
tim
e,
sp
ec
ia
l
in
st
ru
m
en
ts
an
d
co
ns
um
ab
le
s
(d
et
ai
ls
of
ot
he
r
co
st
s
no
tr
ep
or
te
d)
R
ob
ot
ic
:
$9
50
5
C
L
P:
$6
26
0
O
pe
ra
tio
n
tim
e
R
ob
ot
ic
:$
15
76
C
L
P:
N
R
Sp
ec
ia
li
ns
tr
um
en
ts
R
ob
ot
ic
:$
14
87
C
L
P:
N
R
C
on
su
m
ab
le
s
R
ob
ot
ic
:$
18
2
C
L
P
:N
R
N
A
N
A
S
ca
lly
[3
2]
U
SD
20
03
–2
01
0
A
na
ly
si
s
of
M
ed
ic
ar
e
cl
ai
m
s
fr
om
20
03
to
20
10
fo
r
pa
tie
nt
s
w
ho
un
de
rw
en
tb
ar
ia
tr
ic
su
rg
er
y
to
de
te
rm
in
e
im
pa
ct
of
N
C
D
on
co
st
s
Pa
tie
nt
s
(n
=
72
,1
-
17
)
id
en
tif
ie
d
us
in
g
IC
D
-9
co
de
s
an
d
D
R
G
pa
ym
en
t
co
de
s
fo
r
ba
ri
at
ri
c
su
rg
er
y
30
-d
ay
ep
is
od
e
pa
ym
en
ts
ab
st
ra
ct
ed
fr
om
M
ed
ic
ar
e
cl
ai
m
s
P
ay
m
en
ts
fo
r
in
de
x
ho
sp
ita
lis
at
io
n,
re
-a
dm
is
si
on
s,
ph
ys
ic
ia
n
se
rv
ic
es
,
ou
tli
er
pa
ym
en
ts
an
d
po
st
-d
is
ch
ar
ge
an
ci
lla
ry
ca
re
Pr
e-
N
C
D
:
$1
4,
28
3
Po
st
-N
C
D
:
$1
4,
72
0
In
de
x
ad
m
is
si
on
Pr
e-
N
C
D
:
$1
0,
86
5
Po
st
-N
C
D
:
$1
0,
98
0
Ph
ys
ic
ia
n
se
rv
ic
es
Pr
e-
N
C
D
:
$1
95
0
Po
st
-N
C
D
:
$2
29
2
N
A
N
A
N
A
W
ei
ne
r
[2
3]
U
SD
20
05
A
na
ly
si
s
of
B
lu
eC
ro
ss
B
lu
eS
hi
el
d
cl
ai
m
s
da
ta
;
29
,8
20
pr
iv
at
el
y
in
su
re
d
pa
tie
nt
s
L
B
,L
G
B
P,
O
G
B
P,
ot
he
r
re
st
ri
ct
iv
e
su
rg
er
y
an
d
un
kn
ow
n
A
dj
ud
ic
at
ed
in
pa
tie
nt
,
ou
tp
at
ie
nt
an
d
ph
ar
m
ac
y
cl
ai
m
s
on
th
e
in
de
x
da
te
of
su
rg
er
y
(e
.g
.b
ar
ia
tr
ic
su
rg
er
y
ho
sp
ita
lis
at
io
n
pe
ri
od
or
da
y
of
ou
tp
at
ie
nt
su
rg
er
y)
C
om
bi
na
tio
n
of
M
ed
ic
ar
e
re
la
tiv
e
va
lu
e
un
its
an
d
ac
tu
al
ch
ar
ge
s:
in
pa
tie
nt
,p
hy
si
ci
an
an
d
ot
he
r
se
rv
ic
es
pr
ov
id
ed
in
of
fi
ce
,
ph
ar
m
ac
y
an
d
no
n-
in
pa
tie
nt
se
rv
ic
es
cl
ai
m
s
A
ll c
om
bi
ne
d
$2
7,
83
3
L
B
$2
2,
67
0
L
G
B
P
$2
8,
68
5
O
G
B
P
$2
8,
65
3
O
th
er
$2
6,
59
2
U
nk
no
w
n
$2
8,
39
1
In
pa
tie
nt
(i
ns
tit
ut
io
n
an
d
pr
of
es
si
on
al
fe
es
)
L
B
$1
8,
62
2
L
G
B
P
$2
8,
23
7
O
G
B
P
$2
8,
09
6
O
th
er
$2
5,
42
9
U
nk
no
w
n
$2
7,
33
7
Pr
of
es
si
on
al
of
fi
ce
(a
m
bu
la
to
ry
se
rv
ic
es
bi
lle
d)
L
B
$2
8
L
G
B
P
$1
70
O
G
B
P
$1
62
O
th
er
$3
01
U
nk
no
w
n
$3
97
5
O
ut
pa
tie
nt
an
d
ot
he
r
(i
m
ag
in
g,
la
bo
ra
to
ry
)
L
B
$1
94
L
G
B
P
$3
14
O
G
B
P
$1
05
0
O
th
er
$6
83
U
nk
no
w
n
$4
6
Ph
ar
m
ac
y
L
B
$8
5
L
G
B
P
$8
2
O
G
B
P
$5
2
O
th
er
$7
0
U
nk
no
w
n
$3
01
N
A
F
re
zz
a
[3
3]
U
SD
20
06
C
ha
rg
es
fo
r
L
G
B
P
an
d
L
G
B
an
d
co
st
of
in
st
ru
m
en
ts
at
th
e
Te
xa
s
Te
ch
U
ni
ve
rs
ity
H
ea
lth
L
G
B
P
(n
=
93
)
an
d
L
G
B
(n
=
27
)
C
ha
rg
es
an
d
co
st
s
w
er
e
ob
ta
in
ed
fr
om
th
e
ho
sp
ita
l
To
ta
lc
ha
rg
es
,h
os
pi
ta
l
an
d
an
ae
st
he
si
ol
og
y
ch
ar
ge
s;
re
us
ab
le
M
ed
ia
n
to
ta
l
ch
ar
ge
s
L
G
B
P:
$1
0,
42
1
M
ed
ia
n
ho
sp
ita
l
ch
ar
ge
s
L
G
B
P:
$5
78
7
L
G
B
:$
55
06
M
ed
ia
n
an
ae
st
he
si
ol
og
y
ch
ar
ge
s
L
G
B
P:
$1
71
4
R
eu
sa
bl
e
in
st
ru
m
en
ts
(u
ltr
as
ou
nd
,
O
m
ni
D
is
po
sa
bl
e
in
st
ru
-
m
en
ts
fo
r
L
G
B
an
d
N
A
2184 OBES SURG (2017) 27:2179–2192
T
ab
le
1
(c
on
tin
ue
d)
A
ut
ho
r
[r
ef
]
cu
rr
en
cy
ye
ar
a
St
ud
y
de
si
gn
an
d
po
pu
la
tio
n
Ty
pe
(s
)
of
ba
ri
at
ri
c
su
rg
er
y
D
at
a
co
lle
ct
io
n
m
et
ho
ds
C
os
tc
om
po
ne
nt
s
in
cl
ud
ed
To
ta
l
pr
oc
ed
ur
al
co
st
C
os
tc
om
po
ne
nt
on
e
C
os
tc
om
po
ne
nt
tw
o
C
os
t
co
m
po
ne
nt
th
re
e
C
os
t
co
m
po
ne
nt
fo
ur
C
os
t
co
m
po
ne
nt
fi
ve
Sc
ie
nc
e
C
en
te
r
w
er
e
ev
al
ua
te
d
an
d
di
sp
os
ab
le
in
st
ru
m
en
ts
L
G
B
:
$1
0,
49
1
L
G
B
:$
13
69
re
tr
ac
to
r,
ca
m
er
a,
45
°
5
m
m
le
ns
)
Sa
m
e
co
st
fo
r
bo
th
pr
oc
ed
ur
es
;
no
tc
le
ar
w
hi
ch
on
e
is
co
rr
ec
t
$5
0,
97
0
or
$6
1,
97
0
L
G
B
P
ar
e
di
ff
er
en
t,
bu
tl
is
ts
of
ite
m
s
ar
e
to
o
de
ta
ile
d
fo
r
su
m
m
ar
y
L
G
B
P:
$3
51
6
L
G
B
:$
43
63
St
ud
ie
s
re
po
rt
in
g
co
st
s
fo
r
ga
st
ri
c
by
pa
ss
pr
oc
ed
ur
es
A
ng
us
[2
8]
U
SD
20
01
R
et
ro
sp
ec
tiv
e
an
al
ys
es
of
13
3
pa
tie
nt
s
(5
9
pr
iv
at
el
y
in
su
re
d
an
d
74
pu
bl
ic
al
ly
in
su
re
d)
at
th
e
N
as
sa
u
U
ni
ve
rs
ity
M
ed
ic
al
C
en
te
r
fr
om
Ja
nu
ar
y
20
01
to
D
ec
em
be
r
20
01
L
R
Y
G
B
P
(n
=
11
)
an
d
op
en
R
Y
G
B
P
N
o
de
ta
ils
pr
ov
id
ed
co
nc
er
ni
ng
th
e
co
lle
ct
io
n
of
co
st
da
ta
ot
he
r
th
an
ch
ar
ts
w
er
e
re
tr
os
pe
ct
iv
el
y
re
vi
ew
ed
D
ir
ec
t(
op
er
at
iv
e
an
d
ho
sp
ita
ls
er
vi
ce
s)
an
d
in
di
re
ct
co
st
s
L
R
Y
G
B
P:
$6
35
0
SD
$7
5
O
pe
n R
Y
G
B
P
:
$7
89
4
SD
$2
64
D
ir
ec
tc
os
ts
(o
pe
ra
tin
g
ro
om
tim
e,
op
er
at
in
g
ro
om
su
pp
lie
s,
po
st
--
an
ae
st
he
si
a
ca
re
,n
ur
si
ng
,
ph
ar
m
ac
eu
tic
al
di
ag
no
st
ic
an
d/
or
th
er
ap
eu
tic
ra
di
ol
og
ic
st
ud
ie
s)
L
R
Y
G
B
P:
$4
18
0
SD
$3
82
O
pe
n
R
Y
G
B
P:
$3
17
9
SD
$1
01
In
di
re
ct
co
st
s
(h
ou
se
ke
ep
in
g,
ov
er
he
ad
co
st
s,
in
su
ra
nc
e
an
d
em
pl
oy
ee
be
ne
fi
ts
)
L
R
Y
G
B
P:
$1
79
2
SD
$2
63
O
pe
n
R
Y
G
B
P:
$2
13
7
SD
$2
85
N
A
N
A
N
A
N
gu
ye
n
[2
9]
U
SD
20
01
B
et
w
ee
n
M
ay
19
99
an
d
M
ar
ch
20
01
,1
55
pa
tie
nt
s
w
er
e
ra
nd
om
ly
as
si
gn
ed
to
un
de
rg
o
ei
th
er
L
G
B
P
(n
=
79
)
or
O
G
B
P
(n
=
76
)
L
G
B
P
(n
=
68
)
an
d
O
G
B
P
(n
=
68
)
C
os
ts
w
er
e
de
ri
ve
d
fr
om
th
e
U
ni
ve
rs
ity
of
C
al
if
or
ni
a,
D
av
is
,
M
ed
ic
al
C
en
te
r’
s
de
ci
si
on
su
pp
or
t
sy
st
em
da
ta
ba
se
D
ir
ec
t(
op
er
at
iv
e
an
d
ho
sp
ita
ls
er
vi
ce
s
co
st
s)
an
d
in
di
re
ct
co
st
s
L
G
B
P:
$1
4,
08
7
SD
$5
23
7
O
G
B
P:
$1
4,
09
8
SD
$8
52
7
O
pe
ra
tiv
e
co
st
s
(o
pe
ra
tiv
e
tim
e
an
d
su
pp
lie
s
in
cl
ud
in
g
am
or
tis
at
io
n
of
la
pa
ro
sc
op
ic
eq
ui
pm
en
ta
nd
po
st
--
an
ae
st
he
si
a)
L
G
B
P:
$4
92
2
SD
$1
92
7
O
G
B
P:
$3
59
1
SD
$1
00
0
H
os
pi
ta
ls
er
vi
ce
co
st
s
(d
ia
gn
os
tic
,
nu
rs
in
g,
ph
ar
m
ac
eu
tic
al
,
th
er
ap
eu
tic
an
d
ot
he
r)
L
G
B
P:
$2
51
9
SD
$1
71
2
O
G
B
P:
$3
74
2
SD
$3
97
8
In
di
re
ct
co
st
s
(o
ve
rh
ea
d
co
st
s
in
cl
ud
in
g
ad
m
in
is
tr
at
-
iv
e,
fi
na
nc
e,
ho
us
ek
ee
pi
-
ng
,p
ay
ro
ll,
in
su
ra
nc
e
an
d
em
pl
oy
ee
be
ne
fi
ts
)
L
G
B
P:
$6
64
5
SD
$2
43
7
O
G
B
P:
$6
76
5
SD
$4
07
7
D
et
ai
le
d
co
st
br
ea
kd
ow
ns
of
th
e
co
m
po
ne
nt
s
of
op
er
at
iv
e
(o
pe
ra
tiv
e
tim
e/
su
pp
lie
s
an
d
po
st
-a
na
es
th
es
ia
)a
nd
ho
sp
ita
l
se
rv
ic
e
(d
ia
gn
os
tic
,n
ur
si
ng
,
ph
ar
m
ac
eu
tic
al
,t
he
ra
pe
ut
ic
an
d
ot
he
r)
co
st
s
ar
e
pr
ov
id
ed
,
bu
th
av
e
no
tb
ee
n
su
m
m
ar
is
ed
he
re
du
e
to
sp
ac
e
co
ns
id
er
at
io
ns
S
al
ga
do
[2
4]
B
R
L
(R
$)
20
04
/2
00
7
R
et
ro
sp
ec
tiv
e
an
al
ys
is
of
di
re
ct
an
d
in
di
re
ct
co
st
s
in
20
04
an
d
20
07
at
th
e
U
ni
ve
rs
ity
H
os
pi
ta
lo
f
th
e
Fa
cu
lty
of
M
ed
ic
in
e
of
R
ib
ei
ra
o
Pr
et
o-
U
SP
R
ou
x-
en
-Y
ga
st
ri
c
by
pa
ss
by
th
e
st
an
da
rd
ro
ut
e
D
at
a
ob
ta
in
ed
fr
om
th
e
Te
ch
ni
ca
lA
dv
is
or
y
O
ff
ic
e
of
th
e
H
os
pi
ta
l
H
os
pi
ta
lis
at
io
n,
su
rg
er
y
ce
nt
re
,
ex
am
in
at
io
ns
,
m
ed
ic
at
io
ns
an
d
m
at
er
ia
ls
20
04
:
R
$6
84
5
SD
R
$2
80
20
07
:
R
$7
52
6
SD
R
$4
35
H
os
pi
ta
lis
at
io
n
20
04
:R
$2
77
7
20
07
:R
$2
02
0
Su
rg
er
y
ce
nt
re
(i
nc
lu
de
s
an
ae
st
he
si
a)
20
04
:R
$1
91
7
20
07
:R
$3
04
3
E
xa
m
in
at
io
ns
(p
re
-
an
d
po
st
op
er
a-
tiv
e
la
bo
ra
to
ry
M
ed
ic
at
io
ns
(u
se
d
be
fo
re
an
d
af
te
r
su
rg
er
y)
20
04
:R
$3
98
M
at
er
ia
ls
(s
ta
pl
er
s
an
d
ca
th
et
er
s)
20
04
:R
$1
55
2
20
07
:R
$1
98
8
OBES SURG (2017) 27:2179–2192 2185
T
ab
le
1
(c
on
tin
ue
d)
A
ut
ho
r
[r
ef
]
cu
rr
en
cy
ye
ar
a
St
ud
y
de
si
gn
an
d
po
pu
la
tio
n
Ty
pe
(s
)
of
ba
ri
at
ri
c
su
rg
er
y
D
at
a
co
lle
ct
io
n
m
et
ho
ds
C
os
tc
om
po
ne
nt
s
in
cl
ud
ed
To
ta
l
pr
oc
ed
ur
al
co
st
C
os
tc
om
po
ne
nt
on
e
C
os
tc
om
po
ne
nt
tw
o
C
os
t
co
m
po
ne
nt
th
re
e
C
os
t
co
m
po
ne
nt
fo
ur
C
os
t
co
m
po
ne
nt
fi
ve
(n
=
9
in
20
04
an
d
n
=
7
in
20
07
)
an
d
im
ag
in
g)
20
04
:R
$2
01
20
07
:R
$2
11
20
07
:R
$2
71
H
ag
en
[1
8]
U
SD
0.
91
C
H
F
20
11
C
as
e
se
ri
es
of
ga
st
ri
c
by
pa
ss
pa
tie
nt
s
at
th
e
U
ni
ve
rs
ity
H
os
pi
ta
l
G
en
ev
a
fr
om
Ju
ne
19
97
to
Ju
ly
20
10
52
4
O
G
B
P,
32
3
L
G
B
P
an
d
14
3
R
G
B
P
pa
tie
nt
s
D
ec
is
io
n
an
al
yt
ic
m
od
el
us
ed
to
m
od
el
av
er
ag
e
co
st
s;
co
m
pl
ic
at
io
ns
an
d
ho
sp
ita
lis
at
io
n,
O
R
tim
es
co
lle
ct
ed
pr
os
pe
ct
iv
el
y;
IC
U
st
ay
ca
pt
ur
ed
re
tr
os
pe
ct
iv
el
y;
in
st
ru
m
en
tu
se
do
cu
m
en
te
d,
m
at
er
ia
l
fr
om
O
R
pr
ot
oc
ol
s;
co
st
s
fr
om
fi
na
nc
e
de
pa
rt
m
en
ts
O
R
m
at
er
ia
ls
,
po
st
op
er
at
iv
e
IC
U
st
ay
,o
ve
ra
ll
ho
sp
ita
lis
at
io
n
an
d
am
or
tis
at
io
n
of
th
e
ro
bo
tic
sy
st
em
O
G
B
P:
$2
3,
00
0
L
G
B
P:
$2
1,
69
7
R
G
B
P:
$1
9,
36
3
IC
U
st
ay
O
G
B
P:
$7
14
4
L
G
B
P:
$2
14
3
R
G
B
P:
$7
14
H
os
pi
ta
lis
at
io
n
O
G
B
P:
$1
4,
13
7
L
G
B
P:
$1
4,
26
7
R
G
B
P:
$9
59
8
O
pe
ra
tin
g
tim
e
O
G
B
P:
N
R
L
G
B
P:
$3
24
1
R
G
B
P:
$4
60
9
O
R
m
at
er
ia
ls
(l
is
to
f
ite
m
s
to
o
de
ta
ile
d
fo
r
su
m
m
ar
y)
O
G
B
P:
$2
25
1
L
G
B
P:
$5
49
4
R
G
B
P:
$5
42
7
R
ob
ot
ic
am
or
tis
at
io
n
pu
rc
ha
se
pr
ic
e:
$1
,5
92
,5
00
;
ye
ar
ly
m
ai
nt
en
an
ce
fe
e
10
%
;
in
te
re
st
ra
te
5%
;d
ur
at
io
n
of
us
e
of
7
ye
ar
s
Is
m
ai
l[
17
]
U
S$
1.
33
45
-
=
€1
20
14
B
et
w
ee
n
Ja
nu
ar
y
an
d
D
ec
em
be
r
20
12
86
R
G
B
P
pe
rf
or
m
ed
at
St
ra
sb
ou
rg
’s
U
ni
ve
rs
ity
H
os
pi
ta
l
R
G
B
P
(n
=
86
)
In
st
ru
m
en
tc
os
ts
an
d
op
er
at
iv
e
tim
es
pr
ov
id
ed
by
th
e
IG
M
IS
IS
; p
er
so
nn
el
an
d
m
ed
ic
al
de
vi
ce
s’
co
st
s
re
tr
ie
ve
d
fr
om
St
ra
sb
ou
rg
’s
U
ni
ve
rs
ity
H
os
pi
ta
l
M
ed
ic
al
de
vi
ce
s,
pe
rs
on
ne
l,
re
-u
sa
bl
es
an
d
di
sp
os
ab
le
s
$1
0,
73
4
M
ed
ic
al
de
vi
ce
s
$4
32
0
(a
m
or
tis
ed
pu
rc
ha
se
pr
ic
e
an
d
m
ai
nt
en
an
ce
)
Pe
rs
on
ne
l
$1
24
5
(m
ea
n
du
ra
tio
n
pe
r
pe
rs
on
in
O
R
an
d
to
ta
lp
ay
ro
ll
co
st
s;
ad
ju
st
ed
fo
r
ef
fe
ct
iv
e
w
or
ki
ng
ho
ur
s)
R
e-
us
ab
le
s
$1
45
9
(a
cc
ou
nt
s
fo
r
st
er
ili
sa
tio
n
co
st
s
an
d
lif
e
sp
an
of
in
st
ru
m
en
t)
D
is
po
sa
bl
es
$3
63
0
(n
um
be
r
of
un
its
us
ed
m
ul
tip
lie
d
by pu
rc
ha
se
pr
ic
e)
N
A
St
ud
ie
s
re
po
rt
in
g
co
st
s
fo
r
ga
st
ri
c
ba
nd
in
g
pr
oc
ed
ur
es
V
an
G
em
er
t
[3
1]
U
SD
(c
on
ve
rt
ed
fr
om
€
no
co
nv
er
si
on
ra
te
pr
ov
id
ed
)
19
98
21
m
or
bi
dl
y
ob
es
e
pa
tie
nt
s
V
B
G (n
=
21
)
C
os
ts
w
er
e
ba
se
d
on
re
al
pr
ic
es
P
er
-p
at
ie
nt
pe
rf
or
m
an
ce
s
w
er
e
co
un
te
d,
in
cl
ud
in
g
op
er
at
io
n,
re
vi
si
on
al
su
rg
er
y,
di
ag
no
st
ic
an
d
th
er
ap
eu
tic
pr
oc
ed
ur
es
,
m
an
ag
em
en
to
f
su
rg
ic
al
co
m
pl
ic
at
io
ns
,
ou
tp
at
ie
nt
vi
si
ts
an
d
ho
sp
ita
lb
ed
da
ys
$5
86
5
O
pe
ra
tio
ns
(t
im
e
of
su
rg
eo
n,
re
si
de
nt
,
an
ae
st
he
si
ol
og
-
is
t,
nu
rs
in
g
st
af
f;
su
pp
lie
s,
eq
ui
pm
en
t,
co
st
s
of
ho
us
in
g,
fe
ed
in
g,
ad
m
in
is
tr
at
io
n
an
d
m
an
ag
em
en
t)
$2
60
1
L
ab
or
at
or
y/
ra
di
ol
og
y
$3
00
/$
21
9
E
nd
os
co
py
$2
2
Ph
ys
io
th
er
ap
y
$2
5
H
os
pi
ta
l
st
ay
/o
ut
--
pa
tie
nt
vi
si
ts
$2
19
2/
$5
06
K
ea
tin
g
[2
5]
A
U
D
20
06
W
ith
in
-t
ri
al
su
rg
er
y
co
st
s
of
30
pa
tie
nt
s
(n
ot
e
ot
he
r
in
te
rv
en
tio
n
co
st
s
re
po
rt
ed
in
th
e
st
ud
y
w
er
e
ov
er
a
2-
ye
ar
pe
ri
od
an
d
th
er
ef
or
e
on
ly
su
rg
er
y
co
st
s
ar
e
re
po
rt
ed
)
L
A
G
B
C
os
td
at
a
ob
ta
in
ed
fr
om
a
pr
iv
at
e
m
ed
ic
al
sp
ec
ia
lis
t a
nd
pr
iv
at
e
ho
sp
ita
l;
re
so
ur
ce
us
e
do
cu
m
en
te
d
on
pa
tie
nt
ca
se
re
co
rd
fo
rm
s
by
ho
sp
ita
lc
lin
ic
al
st
af
f
S
pe
ci
al
is
tm
ed
ic
al
pe
rs
on
ne
l,
ho
sp
ita
l
pe
rs
on
ne
l,
L
A
G
B
pr
os
th
es
is
,t
he
at
re
su
pp
lie
s,
no
n-
th
ea
tr
e
su
pp
lie
s
an
d
ot
he
r
ex
pe
ns
es
M
ea
n
to
ta
l
su
rg
er
y
co
st
s
$8
52
7
Sp
ec
ia
lis
tm
ed
ic
al
pe
rs
on
ne
l
(s
ur
ge
on
,
su
rg
ic
al
as
si
st
an
t,
an
ae
st
he
tis
t)
$3
00
0
H
os
pi
ta
lp
er
so
nn
el
$9
03
L
A
G
B
pr
os
th
es
is
$3
26
4
T
he
at
re
su
pp
lie
s,
no
n-
th
ea
tr
e
su
pp
lie
s
an
d
ot
he
r
ex
pe
ns
es
$1
65
4
N
A
A
yl
oo
[2
6]
U
SD
20
06
–2
00
9
R
et
ro
sp
ec
tiv
e
re
vi
ew
of
a
pr
os
pe
ct
iv
el
y
m
ai
nt
ai
ne
d
da
ta
ba
se
be
tw
ee
n
M
ar
ch
20
06
an
d
O
ct
ob
er
20
09
fr
om
U
ni
ve
rs
ity
of
Il
lin
oi
s
at
L
A
G
B
(n
=
12
1)
an
d
L
E
SS
(n
=
25
)
D
at
a
en
te
re
d
in
to
de
di
ca
te
d
ba
ri
at
ri
c
da
ta
ba
se
;a
ll
pr
oc
ed
ur
es
pe
rf
or
m
ed
by
on
e
su
rg
eo
n;
de
pr
ec
ia
tio
n
es
tim
at
ed
;
O
pe
ra
tiv
e
tim
e,
co
ns
um
ab
le
s
an
d
la
pa
ro
sc
op
ic
to
w
er
de
pr
ec
ia
tio
n
L
A
G
B
:
$2
0,
34
6
SD
$2
06
9
L
E
SS
:
$2
0,
50
2
SD
$1
88
5
O
pe
ra
tiv
e
tim
e
L
A
G
B
:$
36
30
SD
$6
62
L
E
S
S:
$3
79
3
SD
$5
65
Sp
ec
ia
lis
ed
co
ns
um
ab
le
s
(b
an
d,
di
sp
os
ab
le
st
an
da
rd
or
lo
w
pr
of
ile
tr
oc
ar
s,
su
tu
re
s
an
d
ot
he
r
D
ep
re
ci
at
io
n
of
la
pa
ro
sc
op
ic
to
w
er
eq
ui
pm
en
t;
ba
se
d
on
5-
ye
ar
lif
e
N
A
N
A
2186 OBES SURG (2017) 27:2179–2192
SG procedure. Some of the reported cost estimates were, how-
ever, for open procedures, procedures not commonly performed
(e.g. vertical banded gastroplasty) or surgical techniques likely
to be limited to certain providers (e.g. robot-assisted surgeries).
This limits the generalisability and usefulness of the reported
cost estimates for decision-making purposes as the majority of
bariatric surgeries, worldwide, are performed laparoscopically
using either the RYGB or SG procedure [2].
The inclusion of individual cost components in the total cost
estimates varied widely, although the majority of the studies
included hospitalisation and consumables/material/supply
costs. Interestingly, only three studies explicitly considered
surgeon/physician fees, despite the potential for these costs to
drive differences in total procedural costs between the three
procedures. Consideration of surgeon/physician fees in any fu-
ture analyses will therefore be important, especially for compar-
ing cost estimates between RYGB and SG where equipment/
instrument costs could be quite similar. The variation in includ-
ed cost components can potentially be explained by the lack of a
clearly defined care cycle or timeframe in which resource use
and costs were measured for the majority of studies (only two
studies defined a care cycle [23, 30]), making it difficult to
determine what cost components should be included.
Mean total procedural costs ranged from US$13,307
to US$15,237 depending on the types of studies includ-
ed in the calculation. Excluding studies using charge
data resulted in a lower mean total procedural cost
(US$13,993 vs. US$14,389) and mean total procedural
costs were observed to be lower for gastric bypass com-
pared to gastric banding procedures (US$13,496 vs.
US$15,237). These differences should, however, be
interpreted with slight caution as these mean estimates
are based on a small number of studies conducted in a
number of different countries/settings and for a range of
different procedures (e.g., open, laparoscopic and robot-
assisted). In comparison to the UK tariffs for bariatric
surgery, the mean estimates reported in the literature are
much larger [e.g. £4608 (US$6602) for ‘Stomach bypass
procedures for obesity—HRG code FZ84Z’ and £4,028
(US$5,771) for ‘Restrictive stomach procedures for obe-
sity—HRG code FZ85Z’]. The basis of the UK tariffs
is, however, unknown and their use as a relevant indi-
cator of the accuracy of the costs of bariatric surgery
reported in our review may not be appropriate.
Overall, most studies in the review did not report accurate,
reliable and comprehensive estimates of the total procedural
costs as the inclusion of the ‘important’ costs components
based on recommended costing methods for surgical proce-
dures was poor, with no study including all of the components.
Calculation methods were also poorly reported and usually
did not account for recommended parameters when estimating
costs. This is not surprising as detailed cost information for
interventions is lacking in many clinical areas.Ta
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Systematic reviews of costing studies of bariatric surgery
are limited in the published literature. One relevant study was
identified that reviewed cost approaches for robotic surgeries,
in general [17], and despite the limited overlap in included
studies, our review came to a similar conclusion, namely that
costing studies related to surgical procedures (or specifically
bariatric surgery) have not reported their methods transparent-
ly and largely do not consider ‘important’ cost components
and parameters required for their estimation.
Furthermore, we have attempted to extract details of the
reporting of specific parameters that would be required to
generate appropriate cost estimates according to the formulas
presented by Ismail et al. [17]. Just because a cost component
has been included in an analysis does not mean that parame-
ters required to estimate accurate, reliable and comprehensive
costs have been considered. This point is highlighted in our
review as even when important cost components were includ-
ed, the methods and parameters used in their calculation were
infrequently reported. Our review has also identified some
additional criteria that should be reported to help improve
the quality of cost estimates for bariatric surgery.
Transparent reporting of the methods of identifying and valu-
ing cost components should be provided, as the choice of
method can have an impact on the magnitude of the cost
estimates [13, 14]. An explicit care cycle definition should
also be provided, especially to differentiate between cost esti-
mates that have and have not included costs that are incurred
before and/or after the actual conduct of the procedure, such as
the costs of nutritional and psychological evaluations, 6 to
12 months of medical weight management, re-admissions,
postoperative complications, routine vitamin supplements
and laboratory testing for the life of the patient after surgery.
These additional costs may be significant, but from the avail-
able literature, it is not clear if such costs were considered due
to the lack of care cycle definitions.
Our study does, however, have limitations. First, detailed
costings of bariatric surgery may have been conducted by cer-
tain healthcare providers, but not available in the literature.
This is possibly due to the inclusion of sensitive pricing infor-
mation (e.g. discounts negotiated with manufacturers of certain
equipment) and, therefore, unlikely to be publically available.
Furthermore, our review only identified a small number of
studies, with the majority conducted in a US hospital context.
This makes it difficult to generalise the results of our study to
other settings/jurisdictions, as different equipment, materials
and personnel may be involved across different sites and
Table 2 Total procedural costs of bariatric surgery reported in 2016 US dollars
Author [ref] currency year Type(s) of bariatric surgery Original total cost estimate Inflated, adjusted, 2016
USD total costs estimate
Studies using charge (not cost data)
Cooney [30] USD 2000 Pre-pathway
GB
Post-pathway
GB
$10,176 $8511 $13,468 $11,265
Muhlmann [27] USD 2002 Robotic CLP $9505 $6260 $12,390 $8160
Weiner [23] USD 2005 All types combined $27,833 $33,541
Frezza [33] USD 2006 LGBP LGB $10,421 $10,491 $12,184 $12,265
Scally [32] USD 2010 Pre-NCD Post-NCD $14,283 $14,720 $15,642 $16,120
Studies reporting total costs for gastric bypass procedures
Angus [28] USD 2001 LRYGBP Open RYGBP $6350 $7894 $8405 $10,567
Nguyen [29] USD 2001 LGBP OGBP $14,087 $14,098 $18,645 $18,659
Salgado [24] BRL (R$) 2004/2007 RYGB in 2004 RYGB in 2007 R$6845 R$7526 $8359 $9191
Hagen [18] US$ = 0.91 CHF 2011 OGBP LGBP RGBP ₣20,930 ₣19,744 ₣17,620 $15,575 $14,692 $13,112
Ismail [17] US$1.3345 = €1 2014 RGBP €14,325 $17,751
Studies reporting total costs for gastric banding procedures
VanGemert [31] USD (from € no rate provided) 1998 VGB $5865 $8244
Keating [25] AUD 2006 LAGB AU$8527 $7423
Ayloo [26] USD 2009 LAGB LESS $20,346 $20,502 $22,554 $22,727
Mean total cost estimate (all studies) (n = 23) $14,389 SD $6110
Mean Total Cost Estimate (Only cost data) (n = 14) $13,993 SD $5441
Mean total cost estimate for gastric bypass procedures (only cost data) (n = 10) $13,496 SD $4171
Mean total cost estimate for gastric banding procedures (only cost data) (n = 4) $15,237 SD $8556
AU$ Australian Dollars, BRL Brazilian Real, CHF Swiss Francs, CLP conventional laparoscopic procedures, GB gastric bypass, LAGB laparoscopic
adjustable gastric band, LB laparoscopic banding, LESS laparoendoscopic single-site, LGB laparoscopic gastric banding, LGBP laparoscopic gastric
bypass, LRYGBP laparoscopic Roux-en-Y gastric bypass, NCD National Coverage Determination, OGBP open gastric bypass, RGBP robotic gastric
bypass procedure, RYGBP Roux-en-Y gastric bypass, SD standard deviation, VGB vertical banded gastroplasty
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countries. Caution should, therefore, be made when
interpreting the mean cost estimates presented in our review
in a local context.
Overall, our review indicates that there is a need for up-to-
date costings of the three most common bariatric procedures
(RYGB, AGB and SG). To ensure these costs are collected in
a consistent manner, micro-costing methods have been iden-
tified as the most appropriate approach. We plan to conduct
such a micro-costing study across a number of hospitals of-
fering bariatric surgery within the NHS in England as part of
the BBS study [5, 10]. Our study has been designed to con-
sider all the ‘important’ cost components outlined in this re-
view, will report the parameters involved in their calculation in
a transparent manner and explicitly define the cycle of care to
ensure inclusion of all relevant cost components. We will,
therefore, be able to determine accurate, reliable and compre-
hensive estimates of the cost of bariatric surgery.
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1. exp. Bcosts and cost analysis^/ or exp health care costs/
or exp health expenditures/ or exp hospital costs/
2. bottom-up.ab,hw,kf,kw,ot,sh,ti,tw.
3. 1 and 2
4. (microcost$ or micro-cost$).ab,hw,kf,kw,ot,sh,ti,tw.
5. (bottom-up adj5 cost$).ab,hw,kf,kw,ot,sh,ti,tw.
6. (bottom-up adj5 accounting).ab,hw,kf,kw,ot,sh,ti,tw.
7. (activity-based adj5 accounting).ab,hw,kf,kw,ot,sh,ti,tw.
8. (activity-based adj5 cost$).ab,hw,kf,kw,ot,sh,ti,tw.
9. 3 or 4 or 5 or 6 or 7
10. time study.ab,hw,kf,kw,ot,sh,ti,tw.
11. time motion study.ab,hw,kf,kw,ot,sh,ti,tw.
12. (time and motion method).ab,hw,kf,kw,ot,sh,ti,tw.
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15. time-and-motion study.ab,hw,kf,kw,ot,sh,ti,tw.
16. time motion analysis.ab,hw,kf,kw,ot,sh,ti,tw.
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18. exp bariatric surgery/ or exp gastric bypass/ or exp
jejunoileal bypass/ or exp anastomosis, roux-en-y/ or
exp gastroenterostomy/ or exp gastrostomy/
19. gastric bypass.ab,hw,kf,kw,ot,sh,ti,tw.
20. adjustable gastric banding.ab,hw,kf,kw,ot,sh,ti,tw.
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29. exp obesity/ or exp obesity, morbid/
30. (obesity adj5 severe).ab,hw,kf,kw,ot,sh,ti,tw.
31. (obesity adj5 complex).ab,hw,kf,kw,ot,sh,ti,tw.
32. morbid obes$.ab,hw,kf,kw,ot,sh,ti,tw.
33. weight-loss.ab,hw,kf,kw,ot,sh,ti,tw.
34. 29 or 30 or 31 or 32 or 33
35. 9 and 28—Total hits 1
36. 9 or 17
37. 28 and 36—Total hits 2
38. 1 and 28 and 34—Total hits 327
39. 1 and 28—Total hits 499
40. 1 and 28—Update 26/12/2016 Total hits 16
41. 1 and 28—Update 02/01/2017 Total hits 3
42. 1 and 28—Update 09/01/2017 Total hits 8
43. 1 and 28—Update 16/01/2017 Total hits 3
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OR costs, treatment[MeSH Terms]) OR health
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2. bottom-up[Title/Abstract]
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4. (microcosting[Title/Abstract]) OR micro-costing[Title/
Abstract]
5. bottom-up costing[Title/Abstract]
6. bottom-up accounting[Title/Abstract]
7. activity-based accounting[Title/Abstract]
8. activity-based costing[Title/Abstract]
9. 3 or 4 or 5 or 6 or 7 or 8
10. (time and motion studies[MeSH Terms])
11. time study[Title/Abstract]
12. time motion study[Title/Abstract]
13. time-and-motion method[Title/Abstract]
14. time-and-motion study[Title/Abstract]
15. time motion analysis[Title/Abstract]
16. 10 or 11 or 12 or 13 or 14 or 15
17. ((((((((((bariatric surgery[MeSH Terms]) OR surgeries,
bariatric[MeSH Terms]) OR gastric bypass[MeSH
Terms]) OR gastric bypass, greenville[MeSH Terms])
OR gastric bypass, roux en y[MeSHTerms]) OR bypass,
jejunoileal[MeSH Terms]) OR anastomosis, roux en
y[MeSH Terms]) OR diversion, roux en y[MeSH
Terms]) OR loop, roux en y[MeSH Terms]) OR
g a s t r o e n t e r o s t o m y [M e S H Te r m s ] ) O R
gastrostomy[MeSH Terms]
18. gastric bypass[Title/Abstract]
19. adjustable gastric banding[Title/Abstract]
20. gastric banding[Title/Abstract]
21. sleeve gastrectomy[Title/Abstract]
22. roux-en-y gastric bypass[Title/Abstract]
23. bariatric surgery[Title/Abstract]
24. metabolic surgery[Title/Abstract]
25. weight-loss surgery[Title/Abstract]
26. digestive surgery[Title/Abstract]
27. 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26
28. (obesity[MeSH Terms]) OR morbid obesity[MeSH
Terms]
29. severe obesity[Title/Abstract]
30. complex obesity[Title/Abstract]
31. morbid obesity[Title/Abstract]
32. weight-loss[Title/Abstract]
33. 28 or 29 or 30 or 31 or 32
34. 9 and 27—Total hits 1
35. 9 or 16
36. 27 and 35—Total hits 4
37. 1 and 27 and 33—Total hits 297
38. 1 and 27—Total hits 459
39. 1 and 27—Update 19/12/2016 Total hits 5
40. 1 and 27—Update 26/12/2016 Total hits 1
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